Next-generation influenza vaccines: opportunities and challenges

CJ Wei, MC Crank, J Shiver, BS Graham… - Nature reviews Drug …, 2020 - nature.com
Seasonal influenza vaccines lack efficacy against drifted or pandemic influenza strains.
Developing improved vaccines that elicit broader immunity remains a public health priority …

Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome

RC Borges, MS Hohmann… - International Reviews of …, 2021 - Taylor & Francis
SARS-CoV-2 is the causative agent of the COVID-19 pandemic. This novel coronavirus
emerged in China, quickly spreading to more than 200 countries worldwide. Although most …

Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19

JA Juno, HX Tan, WS Lee, A Reynaldi, HG Kelly… - Nature medicine, 2020 - nature.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
dramatically expedited global vaccine development efforts,–, most targeting the viral …

Integrated immune dynamics define correlates of COVID-19 severity and antibody responses

M Koutsakos, LC Rowntree, L Hensen, BY Chua… - Cell Reports …, 2021 - cell.com
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which
remains ill defined. We analyzed 85 SARS-CoV-2-infected individuals at acute and/or …

Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination

AM Minassian, SE Silk, JR Barrett, CM Nielsen, K Miura… - Med, 2021 - cell.com
Background Development of an effective vaccine against the pathogenic blood-stage
infection of human malaria has proved challenging, and no candidate vaccine has affected …

Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses

H Balachandran, C Phetsouphanh, D Agapiou… - Cell reports, 2022 - cell.com
Understanding the long-term maintenance of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) immunity is critical for predicting protection against reinfection …

Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273

NJM Verstegen, RR Hagen, J van den Dijssel… - Elife, 2022 - elifesciences.org
Background: Patients affected by different types of autoimmune diseases, including common
conditions such as multiple sclerosis (MS) and rheumatoid arthritis (RA), are often treated …

[HTML][HTML] Sensitization in transplantation: assessment of risk (STAR) 2019 working group meeting report

AR Tambur, P Campbell, AS Chong, S Feng… - American Journal of …, 2020 - Elsevier
The purpose of the STAR 2019 Working Group was to build on findings from the initial STAR
report to further clarify the expectations, limitations, perceptions, and utility of alloimmune …

The immune response to SARS-CoV-2 and variants of concern

E Torbati, KL Krause, JE Ussher - Viruses, 2021 - mdpi.com
At the end of 2019 a newly emerged betacoronavirus, severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of severe …

Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors

CM Nielsen, A Ogbe, I Pedroza-Pacheco… - Cell Reports …, 2021 - cell.com
Interactions between B cells and CD4+ T follicular helper (Tfh) cells are key determinants of
humoral responses. Using samples from clinical trials performed with the malaria vaccine …